LLASHNEWSMedical aesthetics media & sourcingRequest Quote
Sourcing & GuidesSkincare OEM

【South Korea】South Korea Government Designates K-Beauty as National Export Priority, Backed by Record $3.1B Q1 2026

Source image preserved for article context.
Editor's note

The Ministry of Finance's designation of cosmetics as a strategic export priority, backed by Finance Minister Koo Yun-cheol's public commitment to regulatory support and public-private partnerships, signals a clear shift in government backing. For buyers, this official endorsement reduces supply-chain risk by ensuring sustained policy and innovation investment in K-beauty's tech-integrated supply chain.

South Korea’s Ministry of Finance has officially designated the cosmetics industry as a strategic export growth engine, signaling stronger government support for K-beauty brands, OEMs, and device makers targeting overseas markets. With Q1 2026 exports hitting $3.1 billion—up nearly 20% year-on-year—and South Korea now ranking as the world’s second-largest cosmetics exporter in 2025, the move underscores a shift toward tech-integrated beauty supply chains.

Government strategy and regulatory backing

Finance Minister Koo Yun-cheol announced during a meeting with major beauty firms that the government will actively foster K-beauty through innovation, regulatory support, and public-private partnerships. The initiative aims to diversify South Korea’s export portfolio beyond semiconductors and electronics by leveraging the country’s technological expertise in AI, data, and devices.

“The K-beauty industry has expanded beyond the cosmetics sector to become a future strategic industry combining AI, data, and devices,” Koo said. The government previously launched the AI Factory Alliance to shift manufacturing toward smart production, which could accelerate time-to-market and product quality for beauty suppliers.

Export milestones and competitive landscape

According to the Ministry of Food and Drug Safety, South Korea’s cosmetics exports reached $3.1 billion in Q1 2026, a nearly 20% increase from the same period in 2025. In 2025, total shipments hit $11.4 billion, overtaking the United States ($10.8 billion) and trailing only France ($24.3 billion). Industry observers note that K-beauty’s growth trajectory suggests it may close the gap with France faster than expected.

Retail and brand expansion signals

Olive Young, South Korea’s top beauty retailer, made its U.S. brick-and-mortar debut with an 803-square-meter store in Pasadena, California, offering 400 brands and 5,000 products. The location features personalized services including skin scans, scalp analysis, and a Beauty Lab for skincare lessons. CEO Lee Sun-jung stated, “International customers used to visit Olive Young stores when they came to Korea; now we are bringing Olive Young directly to customers in major global markets.”

Dr. Althea is expanding across the U.S. through the Olive Young location, focusing on gentle, barrier-supporting formulas. Founder Evelyn Lee said, “Our expansion into Olive Young in the Los Angeles area is an exciting step for Dr. Althea as we continue to grow our presence in the US market.” Meanwhile, Cosrx achieved the number-one best-selling beauty product spot on Amazon Germany with its Ultra-Light Invisible Sunscreen SPF50+, reflecting European demand for weightless sun protection.

Sourcing context and buyer implications

For overseas importers and distributors, the Korean government’s commitment signals increased R&D investment in AI-driven manufacturing and regulatory streamlining, potentially improving supply chain reliability and product innovation. The rise of K-beauty in Europe and India—exemplified by Cosrx’s Amazon Germany success and KorinMi’s $1.045 million funding for Korean beauty clinics in India—indicates growing demand beyond traditional Asian markets.

“India offers a high-growth potential for K-beauty expansion,” noted an Innova Market Insights analyst, citing geopolitical shifts diverting business strategies toward Asia. Buyers should monitor regulatory updates from South Korea’s Ministry of Food and Drug Safety and explore partnerships with brands leveraging AI and device integration for differentiated product offerings.

What buyers should watch

Distributors and clinic buyers should track South Korea’s AI Factory Alliance outcomes, which could reduce lead times and enhance product consistency for OEM/ODM partners. The Olive Young U.S. expansion model—combining retail with diagnostic services—may signal a new channel for medical aesthetics devices and consumables. Additionally, Cosrx’s Amazon Germany performance highlights the potential for K-beauty sunscreens and barrier-support products in European e-commerce, a segment worth evaluating for cross-border procurement strategies.

Source: Read the original report | Published: June 04, 2026